Spica Healthcare — Unit of Grover Hospital, Bathinda
HomeHealth Guides & BlogsMedical Oncology & ChemotherapyOvarian Epithelial Carcinoma: Primary Debulking vs. Neoadjuvant Paclitaxel-Carboplatin and Maintenance Niraparib
Medical Oncology & Chemotherapy

Ovarian Epithelial Carcinoma: Primary Debulking vs. Neoadjuvant Paclitaxel-Carboplatin and Maintenance Niraparib

11 min read
Sep 6, 2026
Spica Healthcare Clinical & Surgical Protocol Illustration #130

Clinical Summary & Key Takeaways

A state-of-the-art gynecologic oncology review on High-Grade Serous Ovarian Carcinoma (HGSOC), evaluating primary cytoreductive surgery vs. interval debulking, CA-125 kinetics, germline/somatic BRCA and HRD testing, and maintenance PARP inhibitors (Olaparib, Niraparib).

CRITICAL CLINICAL RED FLAG: Persistent abdominal bloating, early satiety, pelvic pain, and increased urinary frequency lasting more than 12 days a month in postmenopausal women requires immediate pelvic transvaginal ultrasound and serum CA-125 measurement.

1. Pathology & Origin: The Fallopian Tube Fimbriae Secret

Over 80% of High-Grade Serous Ovarian Carcinomas (HGSOC) originate from Serous Tubal Intraepithelial Carcinomas (STIC) in the fimbriated end of the fallopian tubes rather than the ovarian surface epithelium. Characterized by universal TP53 mutations and high genomic instability.

  • Homologous Recombination Deficiency (HRD): Present in up to 50% of HGSOC cases (BRCA1/2 mutations or genomic scar positivity).

  • Peritoneal Seeding: Ovarian cancer exfoliates malignant cells into peritoneal fluid, seeding the omentum, diaphragm, and bowel mesentery.

2. Primary Cytoreductive Surgery vs. Neoadjuvant Chemotherapy

The goal of cytoreductive surgery is complete macroscopic resection (R0, zero residual disease):

  1. Primary Debulking Surgery (PDS): Total abdominal hysterectomy, bilateral salpingo-oophorectomy, infracolic omentectomy, and peritonectomy.

  2. Neoadjuvant Chemotherapy (NACT): 3 cycles of Paclitaxel (175 mg/m²) + Carboplatin (AUC 5-6) administered prior to Interval Debulking Surgery (IDS) in patients with high-burden unresectable disease or poor performance status.

"Achieving complete macroscopic cytoreduction (R0 with zero residual visible disease) combined with frontline PARP inhibitor maintenance yields unprecedented long-term remission in ovarian cancer." — Dr. Neha Gupta
Spica Healthcare Clinical & Surgical Protocol Illustration #130
Spica Healthcare Clinical & Surgical Protocol Illustration #130

3. Frontline PARP Inhibitor Maintenance (SOLO-1 & PRIMA Trials)

Following platinum-response, oral PARP inhibitors (Olaparib for BRCA-mutated, Niraparib for HRD-positive/all-comers) inhibit single-strand DNA break repair, driving HRD cancer cells into catastrophic double-strand breaks and synthetic lethality.

CLINICAL CAUTION: Laparoscopic aspiration of an intact cystic ovarian mass is strictly contraindicated due to the risk of tumor spillage converting a curable Stage I cancer into an advanced Stage IC.

4. Surveillance & CA-125 Monitoring

Clinical evaluation and serum CA-125 every 3 months for 2 years, combined with cross-sectional CT/PET imaging for any biological surge, enables early intervention.

5. Peer-Reviewed References & Clinical Guidelines

1. Maintenance Olaparib for Patients with Newly Diagnosed Advanced Ovarian Cancer (SOLO-1 Trial) — NEJM, 2018; 379: 2495-2505.

2. Niraparib in Patients with Newly Diagnosed Advanced Ovarian Cancer (PRIMA Trial) — NEJM, 2019; 381: 2391-2402.

Frequently Asked Patient Questions

Limb Salvage with modular titanium megaprosthesis removes the tumor completely while preserving the limb, allowing patients to walk, work, and maintain full social independence without the physical disability of an artificial limb.

Dr. Neha Gupta - Clinical Director & Senior Medical Oncologist

Senior Consultant & Clinical Director — Medical Oncology

MBBS (BFUHS Faridkot), MD Radiation Oncology (BFUHS Faridkot), DrNB Medical Oncology (Sarvodaya Hospital, Faridabad), Precision Oncology (Harvard, USA), Ex Consultant RGCI New Delhi

Share this medical guide:
WhatsApp
Director-Led Clinical Breakthroughs

Signature Surgical Innovations & Techniques

Proprietary surgical methodologies and precision protocols pioneered by our senior directors to minimize trauma, protect natural anatomy, and accelerate recovery.

1 of 13
Comprehensive Bone Cancer Oncology & Limb Preservation
Click to Watch Video Demonstration
95%+ Limb Salvage & MAP Chemotherapy
Multidisciplinary Limb Salvage, MAP Chemotherapy & Modular Megaprosthetics

Comprehensive Bone Cancer Oncology & Limb Preservation

Dr. Deepak Garg (Orthopaedic Surgical Oncology - RGCI Delhi Trained) and Dr. Neha Gupta (Medical Oncology) co-lead the Bone Cancer & Sarcoma Center at Spica Healthcare. Integrating intensive multi-agent neoadjuvant chemotherapy protocols (MAP: High-Dose Methotrexate, Doxorubicin, Cisplatin for Osteosarcoma; VIDE: Vincristine, Ifosfamide, Doxorubicin, Etoposide for Ewing Sarcoma) with 3D computer-navigated limb salvage surgery and modular titanium megaprosthetic joint reconstruction, 5-year survival rates exceed 75% to 80% while saving over 95% of patients from limb amputation.

Key Advantages Over Conventional Surgery:
Coordinated Surgical & Medical Oncology: Seamless dual leadership under Dr. Deepak Garg & Dr. Neha Gupta
95%+ Limb Preservation Rate: Wide oncological bone resection avoiding traumatic limb amputations
High-Grade Sarcoma Chemotherapy: Standardized MAP and VIDE protocols delivering high tumor necrosis rates (>90%)
Custom Modular Megaprostheses: Immediate joint restoration with biological tendon ingrowth collars
Why Families & Physicians Trust Spica

World-Class Clinical Precision, Built on Compassion

Spica Healthcare — Bone and Cancer Institute, Bathinda — is South-Western Punjab's premier super-speciality centre led by AIIMS and Tata Memorial fellowship-trained directors.

AIIMS & Tata Memorial Alumni25+ Yrs Combined Senior Leadership

15,000+ Complex Surgeries & 100% Director-Led Evaluations

Every diagnostic MRI review, surgical staging, and operation is personally directed by chief clinical specialists — Dr. Deepak Garg (Orthopaedic Oncology & Robotics) and Dr. Neha Gupta (Medical Oncology) — guaranteeing zero junior proxies.

15,000+Surgeries Completed
95%+Limb Salvage Rate
<0.3%Infection Benchmark
Pre-Op 3D Virtual Planning 100% Direct Director OPD Day-1 Walking Protocol
Sub-Millimeter Accuracy

3D Navigated Robotics & Day-1 Walking

Sub-millimeter implant positioning and soft-tissue ligament balancing ensuring patients walk comfortably within 24 hours of total knee replacement.

ROSA Robotics & Stryker Nav
Malwa Punjab Exclusive

Limb-Salvage Over Amputation

South-West Punjab's only dedicated centre for modular titanium megaprosthesis, saving natural limbs and functions in 95%+ of bone cancer patients.

Modular Megaprosthesis
0-Out-Of-Pocket Options

100% Cashless PM-JAY & TPAs

Full cashless coverage for Ayushman Bharat (PM-JAY), Punjab Govt Health Schemes, ECHS, and 30+ private insurance networks with on-desk approvals.

Ayushman + 30+ TPAs Empanelled
24/7 Tertiary Ready

Class-100 Laminar Flow OTs & ICU

Positive-pressure HEPA filtered theatres minimizing infection rates below international benchmarks with 24/7 dedicated critical care backup.

Spica Healthcare Bathinda
Expert Surgical Directors

Meet the Doctors at Spica Healthcare

Fellowship-trained surgical directors from AIIMS & Tata Memorial providing compassionate, world-class tertiary care in super-speciality orthopaedics and medical oncology.

Dr. Neha Gupta - Clinical Director & Senior Medical Oncologist

Dr. Neha Gupta

Senior Consultant & Clinical Director — Medical Oncology

13+ Yrs Exp

MBBS (BFUHS Faridkot), MD Radiation Oncology (BFUHS Faridkot), DrNB Medical Oncology (Sarvodaya Hospital, Faridabad), Precision Oncology (Harvard, USA), Ex Consultant RGCI New Delhi

Medical Oncology & ChemotherapyImmunotherapy & Targeted OncologyPrecision Oncology & Cancer GenomicsPreventive Cancer ScreeningPalliative & Supportive OncologyHormonal TherapyComprehensive Cancer Treatments
Dr. Deepak Garg - Director & Senior Joint Replacement, Spine and Orthopaedic Oncologist

Dr. Deepak Garg

Senior Consultant & Clinical Director — Orthopaedic Oncology & Robotic Joint Surgery

16+ Yrs Exp

MBBS (TNMC Mumbai), DNB Orthopaedics (PGI & SP Miraj), Fellowship Arthroplasty and Arthroscopy (Fortis Hospital, New Delhi), Fellowship Orthopaedic Oncology (Rajiv Gandhi Cancer Institute, New Delhi)

Orthopaedic Oncology & Bone Tumors3D Robotic Joint ReplacementSports Injuries & ArthroscopyTrauma & Fracture ReconstructionGeneral Orthopaedics & Spine CareComprehensive Cancer Treatments
Community Health & Academic Outreach

Upcoming Health Camps & Academic Events

Free OPD screening camps, director-led masterclasses, and national oncology representations by Spica Healthcare.

Curious what families & patients experience

Hear what our patients are saying

Real stories from patients who recovered through limb preservation surgery, 3D robotic joint replacements, and precision cancer care at Spica Healthcare — Grover Hospital, Bathinda.

Health Knowledge & Clinical Guides

Doctor-Authored Health Guides

Evidence-based surgical recovery roadmaps, robotic joint protocols, and precision oncology insights written by our clinical directors.